Seres Therapeutics (MCRB) Stock Price & Financial Analysis
Seres Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Seres Therapeutics
What is the current stock price for MCRB?
As of the latest trading session, MCRB stock trades at $9.27. The 52-week range is $6.53–$29.98, with a day range of $8.76–$9.34.
What is the P/E ratio for MCRB?
Seres Therapeutics's trailing P/E ratio is 14.4, meaning investors pay $14.4 for every $1 of annual earnings. Seres Therapeutics operates in the Healthcare sector.
Does MCRB pay dividends?
Seres Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MCRB?
Based on 1 analyst, the consensus for MCRB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of MCRB?
Seres Therapeutics's market capitalization is $81.3M, classifying it as a micro-cap company. Seres Therapeutics operates in the Healthcare sector within the Biotechnology industry.